Tolemy Bio is building an AI-native control panel for cell-derived medicines, combining virtual cell models, biological data, and wet-lab experimentation.
Tolemy Bio aims to make cell biology more predictable, programmable, and scalable.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The control panel combines virtual cell models, biological data, and wet-lab experimentation to help direct cellular systems toward therapeutic outcomes.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated August 31, 2026, September 3, 2026, September 11, 2026, September 13, 2026, September 18, 2026, September 21, 2026, September 26, 2026 and September 27, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.